Content about Intellectual property law

March 21, 2014

Actavis earlier this week announced that it has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to Actavis' generic version of Daytrana (methylphenidate transdermal system).

DUBLIN — Actavis earlier this week announced that it has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to Actavis' generic version of Daytrana (methylphenidate transdermal system). Daytrana is a CNS stimulant indicated for the treatment of attention deficit hyperactivity disorder.

December 12, 2013

Vitamin Shoppe announced that the company had filed suit against law firm Seeger Weiss in New York federal court.

NORTH BERGEN, N.J. — Vitamin Shoppe on Wednesday announced that the company had filed suit against law firm Seeger Weiss in New York federal court. Seeger Weiss has been using the company's name and trademark "Vitamin Shoppe" in its domain name and marketing materials, as well as the trademarked Bodytech name in marketing and soliciting materials without the company's permission, Vitamin Shoppe charged. 

July 13, 2012

A federal judge has ruled in favor of pharmacy technology manufacturer Innovation Associates in a 6-year-old case brought by ScriptPro concerning a component of one of Innovation's dispensing robots, the companies said.

NEW YORK — A federal judge has ruled in favor of pharmacy technology manufacturer Innovation Associates in a 6-year-old case brought by ScriptPro concerning a component of one of Innovation's dispensing robots, the companies said.

December 1, 2011

Generic drug maker Mylan and a partnering company are challenging the patent on a contraceptive drug.

PITTSBURGH — Generic drug maker Mylan and a partnering company are challenging the patent on a contraceptive drug.

Mylan said Thursday that it and Famy Care had been sued by Warner Chilcott in the U.S. District Court for the District of New Jersey following their filing of a regulatory approval application with the Food and Drug Administration for norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets, a generic version of Warner Chilcott's Generess Fe.

October 11, 2011

Drug maker Warner Chilcott's diversified portfolio of drugs will help it weather generic challenges to its patents, according to a new report by Zacks Investment Research.

NEW YORK — Drug maker Warner Chilcott's diversified portfolio of drugs will help it weather generic challenges to its patents, according to a new report by Zacks Investment Research.

May 31, 2011

Procter & Gamble announced that it has filed a lawsuit against a private-label manufacturer and distributor of mouthwash for allegedly violating the former's intellectual property.

CINCINNATI — Procter & Gamble announced that it has filed a lawsuit against a private-label manufacturer and distributor of mouthwash for allegedly violating the former's intellectual property.

P&G claimed in its suit, filed in the U.S. District Court for the Southern District of Ohio, that Vi-Jon's mouthwash product carries a bottle and label shape design that is too similar to P&G's Scope Outlast mouthwash.

October 10, 2010

Your company’s ideas may be as valuable as your products. Many of today’s most relevant and distinct brands, such as Oakley sunglasses, Under Armour, Axe, Aveeno, Apple, Method, Stonyfield yogurt and Whole Foods, have one thing in common: Each of these brands may not be the largest in its category, but it is the best at creating emotional connections with its core consumer.

Your company’s ideas may be as valuable as your products.

Many of today’s most relevant and distinct brands, such as Oakley sunglasses, Under Armour, Axe, Aveeno, Apple, Method, Stonyfield yogurt and Whole Foods, have one thing in common: Each of these brands may not be the largest in its category, but it is the best at creating emotional connections with its core consumer. They are brands that are well positioned in the consumer’s mind and supported by an array of corporate assets—many of them intangible. What is their secret?

August 30, 2010

Salix Pharmaceuticals announced its agreement with Novel Labs to settle its patent litigation over Novel’s...

RALEIGH, N.C. Salix Pharmaceuticals announced its agreement with Novel Labs to settle its patent litigation over Novel’s proposed generic version of MoviPrep.